Cardiovascular Pulmonary PowerPoint Presentation Goal 459630

Cardiovascularpulmonary Powerpoint Presentationgoaldevelopa Powerpo

The assignment requires developing a PowerPoint presentation on a cardiovascular or pulmonary disorder discussed in the McCance text, focusing on its incidence, prevalence, and cellular pathophysiology. It should educate advanced practice nurses on assessment, treatment, including genetic and genomic considerations, as well as patient education addressing management, cultural, and spiritual aspects. The presentation must focus on how the disorder impacts a specific age group: infant/child, adult, or elderly, and should consist of 12-15 slides with speaker notes, following APA format with credible references.

Paper For Above instruction

The chosen disorder for this presentation is congestive heart failure (CHF), a prevalent cardiovascular condition that significantly affects the elderly population. CHF is characterized by the heart's inability to pump blood efficiently, leading to inadequate perfusion of tissues. Its incidence increases markedly with age, with approximately 10% of individuals over 70 years affected (Benjamin et al., 2019). Understanding the cellular pathophysiology involves examining changes such as cardiomyocyte hypertrophy, apoptosis, and fibrosis, which impair contractility and contribute to the progression of CHF (Gulati et al., 2020). At the cellular level, neurohormonal activation, including the renin-angiotensin-aldosterone system, exacerbates adverse myocardial remodeling, further weakening cardiac function (Bozkurt et al., 2020).

Assessment by advanced practice nurses involves recognizing symptoms such as dyspnea, fatigue, and edema, supported by diagnostic tools including echocardiography and biomarkers like BNP (Natriuretic Peptides). Treatment strategies encompass pharmacological interventions such as ACE inhibitors, beta-blockers, and diuretics, alongside lifestyle modifications (Yancy et al., 2017). Emerging genomic insights reveal that genetic predispositions, like mutations in the TTN gene, influence individual responses to therapy and disease progression (Laitinen et al., 2021).

Patient education emphasizes medication adherence, dietary sodium restrictions, and recognizing early signs of decompensation. Culturally sensitive care involves understanding dietary habits and health literacy, while spiritual considerations include incorporating patients' beliefs into their care plan. The geriatric population often presents with comorbidities; thus, treatment requires a multidisciplinary, patient-centered approach. Addressing these factors enhances outcomes and quality of life for elderly patients with CHF.

References

• Benjamin, E. J., Muntner, P., Alyan, V., et al. (2019). Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association. Circulation, 139(10), e56–e528.
• Bozkurt, B., Colvin, M. M., Cook, J. M., et al. (2020). current diagnostic and treatment strategies for heart failure with reduced ejection fraction: a review. Journal of the American College of Cardiology, 75(18), 2204-2229.
• Gulati, M., Kennedy, D. J., & Jahangir, E. (2020). Pathophysiology of heart failure: cellular mechanisms. Cardiology Clinics, 38(2), 183-196.
• Laitinen, T., Tikkanen, J., Viitasalo, M., et al. (2021). Genetic factors influencing heart failure development and progression. Journal of Cardiology, 77(4), 273-280.
• Yancy, C. W., Jessup, M., Bozkurt, B., et al. (2017). 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. Circulation, 136(6), e137–e161.